Roivant Sciences Ltd. financial metrics

Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic. Latest period: Q4 2025.

Symbol
ROIV on Nasdaq
Location
London
Fiscal year end
31 March
Latest financial report
06 Feb 2026

Quick Takeaways

  • ROIV - Roivant Sciences Ltd. financial facts are built from SEC company filings data.
  • Latest metrics period on this page: Q4 2025.
  • Headline metric: Return On Equity -19%.

What Changed

  • Return On Equity YoY change: <span class="text-green-600">+727%</span>.
  • Most recent SEC facts end date: 02 Feb 2026.

Why This Matters

  • This gives a beginner-friendly first read before you inspect detailed formulas and metric tables.
  • Every metric card links to a deeper SEC-backed history page for verification.

Official SEC Source

Based on latest 10-Q/10-K

Facts and ratios are grounded in SEC company facts linked to the latest 10-Q/10-K cycle.

See Original Filing

Latest SEC snapshot (2026-02-02) highlights Return On Equity -19.1%, Return On Assets -14.5%, and Operating Margin -16965.3%.

Financial Quality Score

Transparent 0-100 scoring model based on profitability, financial health, and growth factors.

18.0/100

Weak Confidence high

Return On Equity

-19%

Metric score 0.0/100

Return On Assets

-14%

Metric score 0.0/100

Financial Health

Current Ratio
30.66x
Quick Ratio
29.81x
Debt to Equity
0.02x

Strengths

Debt-to-equity

Watchpoints

Return On Equity, Return On Assets, and Operating Margin

Key metrics snapshot

Return On Equity

-19%

YoY: +727%

Industry median: -43% (n=675)

View history

Return On Assets

-14%

YoY: +725%

Industry median: -47% (n=673)

View history

Operating Margin

-16965%

YoY: +42%

Industry median: -121% (n=298)

View history

Current Ratio

30.66x

YoY: -19%

Industry median: 3.39x (n=667)

View history

Quick Ratio

29.81x

YoY:

Industry median: 1.51x (n=289)

View history

Debt-to-equity

0.02x

YoY: -47%

Industry median: 0.26x (n=530)

View history

Revenues YoY

-0.39%

YoY:

Industry median: 7.3% (n=302)

View history

NetIncomeLoss YoY

-594%

YoY:

Industry median: -0.93% (n=641)

View history

Profitability

Metric Latest value YoY change
Return On Equity -19% +727%
Return On Assets -14% +725%
Operating Margin -16965% +42%

Financial Health

Metric Latest value YoY change
Current Ratio 30.66x -19%
Quick Ratio 29.81x
Debt-to-equity 0.02x -47%

Growth

Metric Latest value YoY change
Revenues YoY -0.39%
NetIncomeLoss YoY -594%

Share Metrics

Metric Latest value YoY change
Entity Common Stock, Shares Outstanding 715,701,137 +0.3%
Common Stock, Shares, Outstanding 709,689,411 -1.4%
Common Stock, Value, Issued $0
Weighted Average Number of Shares Outstanding, Basic 696,859,682 -3.6%
Weighted Average Number of Shares Outstanding, Diluted 696,859,682 -3.6%

Additional Metrics

Metric Latest value YoY change
Revenue from Contract with Customer, Excluding Assessed Tax $13,310,000 -0.39%
Research and Development Expense $628,105,000 +26%
General and Administrative Expense $599,308,000 +24%
Operating Income (Loss) $1,215,273,000 -42%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $921,729,000 -86%
Income Tax Expense (Benefit) $84,297,000
Earnings Per Share, Basic -1.17 -11800%
Earnings Per Share, Diluted -1.16 -5900%
Cash and Cash Equivalents, at Carrying Value $1,478,270,000 -26%
Marketable Securities, Current $3,051,708,000 -3.3%
Cash, Cash Equivalents, and Short-term Investments $4,529,978,000 -12%
Other Assets, Current $129,912,000 -40%
Assets, Current $4,659,890,000 -13%
Property, Plant and Equipment, Net $13,447,000 -0.86%
Operating Lease, Right-of-Use Asset $83,561,000 -8.1%
Other Assets, Noncurrent $34,563,000 +2%
Assets $5,225,368,000 -9.8%
Accounts Payable, Current $13,294,000 -44%
Employee-related Liabilities, Current $38,112,000 -3%
Accrued Liabilities, Current $117,991,000 +13%
Liabilities, Current $151,964,000 +7.4%
Operating Lease, Liability, Noncurrent $98,503,000 +8.9%
Other Liabilities, Noncurrent $677,000 +121%
Liabilities $251,144,000 -2%
Accumulated Other Comprehensive Income (Loss), Net of Tax $20,610,000 +156%
Retained Earnings (Accumulated Deficit) $694,998,000 -251%
Stockholders' Equity Attributable to Parent $4,269,255,000 -18%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $4,974,224,000 -10%
Liabilities and Equity $5,225,368,000 -9.8%
Common Stock, Shares Authorized 7,000,000,000 0%
Common Stock, Shares, Issued 709,689,411 -1.4%
Common Stock, Par or Stated Value Per Share 0
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1,488,770,000 -26%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $796,687,000 -886%
Operating Lease, Liability, Current $10,436,000 +6.1%
Additional Paid in Capital $4,943,643,000 +4.7%

How we score

This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.

Metric Weight V1 threshold
ROIC205% to 20%
ROE158% to 25%
ROA102% to 10%
Operating Margin55% to 25%
Current Ratio121.0x to 2.0x
Quick Ratio80.8x to 1.5x
Debt to Equity100.3x to 2.0x (lower is better)
Revenue YoY10-10% to +20%
Net Income YoY10-10% to +20%

How Calculated (standard_v1)

Metrics are computed with a market-consensus convention designed for cross-portal comparability.

  • TTM Operating Income / TTM Revenues
  • Current Assets / Current Liabilities (latest instant quarter)
  • (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
  • Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
  • TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
  • TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
  • TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
  • TTM Revenues YoY
  • TTM Net Income YoY